Title : Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway.

Pub. Date : 2021 Aug 5

PMID : 34354046






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2/STAT3/MCL-1 signaling pathway. gemcitabine MCL1 apoptosis regulator, BCL2 family member Homo sapiens